<VariationArchive RecordType="classified" VariationID="16240" VariationName="NM_001382289.1(FSHB):c.236_237del (p.Val79fs)" VariationType="Deletion" Accession="VCV000016240" Version="10" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2023-10-15" DateCreated="2016-08-22" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31279" VariationID="16240">
      <GeneList>
        <Gene Symbol="ARL14EP-DT" FullName="ARL14EP divergent transcript" GeneID="105376607" HGNC_ID="HGNC:55517" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="30042970" stop="30322946" display_start="30042970" display_stop="30322946" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="FSHB" FullName="follicle stimulating hormone subunit beta" GeneID="2488" HGNC_ID="HGNC:3964" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="30231014" stop="30235194" display_start="30231014" display_stop="30235194" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="30252562" stop="30256823" display_start="30252562" display_stop="30256823" Strand="+" />
          </Location>
          <OMIM>136530</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001382289.1(FSHB):c.236_237del (p.Val79fs)</Name>
      <CanonicalSPDI>NC_000011.10:30233644:GTG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="30233645" stop="30233646" display_start="30233645" display_stop="30233646" variantLength="2" positionVCF="30233644" referenceAlleleVCF="AGT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="30255192" stop="30255193" display_start="30255192" display_stop="30255193" variantLength="2" positionVCF="30255191" referenceAlleleVCF="AGT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V79fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.30233646_30233647del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.30233646_30233647del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.30255193_30255194del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.30255193_30255194del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008144.1" sequenceAccession="NG_008144" sequenceVersion="1" change="g.7631_7632del">
            <Expression>NG_008144.1:g.7631_7632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000510.4" sequenceAccession="NM_000510" sequenceVersion="4" change="c.236_237del">
            <Expression>NM_000510.4:c.236_237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000501.1" sequenceAccession="NP_000501" sequenceVersion="1" change="p.Val79fs">
            <Expression>NP_000501.1:p.Val79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018080.3" sequenceAccession="NM_001018080" sequenceVersion="3" change="c.236_237del">
            <Expression>NM_001018080.3:c.236_237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018090.1" sequenceAccession="NP_001018090" sequenceVersion="1" change="p.Val79fs">
            <Expression>NP_001018090.1:p.Val79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382289.1" sequenceAccession="NM_001382289" sequenceVersion="1" change="c.236_237del" MANESelect="true">
            <Expression>NM_001382289.1:c.236_237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369218.1" sequenceAccession="NP_001369218" sequenceVersion="1" change="p.Val79fs">
            <Expression>NP_001369218.1:p.Val79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000510.2" sequenceAccession="NM_000510" sequenceVersion="2" change="c.236_237delTG">
            <Expression>NM_000510.2:c.236_237delTG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212966" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="136530.0001" DB="OMIM" />
        <XRef Type="rs" ID="5030646" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 8220432 Fig. 1 to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001382289.1(FSHB):c.236_237del (p.Val79fs) AND Hypogonadotropic hypogonadism 24 without anosmia" Accession="RCV000017627" Version="34">
        <ClassifiedConditionList TraitSetID="5270">
          <ClassifiedCondition DB="MedGen" ID="C5574957">Hypogonadotropic hypogonadism 24 without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001382289.1(FSHB):c.236_237del (p.Val79fs) AND not provided" Accession="RCV000522577" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-06-03" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-03" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-08-22" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20488225</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4344039</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8220432</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9271483</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9280841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9624193</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5270" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1295" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated follicle-stimulating hormone (FSH) deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated FSH deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA</ElementValue>
                <XRef Type="MIM" ID="229070" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 24 without anosmia</ElementValue>
                <XRef ID="MONDO:0009239" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Follicle-stimulating hormone deficiency, isolated</ElementValue>
                <XRef ID="Follicle-Stimulating+Hormone+Deficiency%2C+Isolated/2892" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HH24</ElementValue>
                <XRef Type="MIM" ID="229070" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10128" />
                <XRef ID="10128" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="52901" DB="Orphanet" />
              <XRef ID="C5574957" DB="MedGen" />
              <XRef ID="MONDO:0009239" DB="MONDO" />
              <XRef Type="MIM" ID="229070" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4048912" SubmissionDate="2022-01-25" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000510.2(FSHB):c.236_237del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002069221" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the FSHB gene demonstrated a two base pair deletion in exon 3, c.236_237del. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 26 amino acids downstream of the mutation, p.Val79Glufs*27. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated FSHB protein with potentially abnormal function. This sequence change has previously been described in the homozygous state in a female patient with infertility, primary amenorrhea, with undetectable serum FSH (PMID: 8220432). This variant is also reported to occur in the compound heterozygous state with a pathogenic missense variant in another patient with similar features (PMID: 9271483).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FSHB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000510.2:c.236_237del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37904" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="136530.0001_HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA" title="FSHB, 2-BP DEL, 2631TG_HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA" />
        <ClinVarAccession Accession="SCV000037904" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-11-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Italian woman with primary amenorrhea and infertility associated with isolated deficiency of pituitary FSH (HH24; 229070) and normal LH (see LHB, 152780) secretion, Matthews et al. (1993) found homozygosity for a 2-bp frameshift deletion in exon 3 of the FSHB gene. The proband's mother and son were heterozygous for the deletion. The mother had been amenorrheic and infertile for 6 years before conception of her only child; the proband's father was deceased, and no information was available regarding his fertility. Codon 61 in exon 3 was changed from GTG (val) to GAG (glu) by deletion of the second and third nucleotides. The deletion resulted in an alteration of amino acid codons 61 through 86, followed by a premature stop codon. The predicted truncated beta subunit lacked regions that are important for association with the alpha subunit (see 118850), and for binding to and activation of the FSH receptor (FSHR; 136435). Abnormalities of FSH structure or function may represent an underrecognized but treatable cause of infertility; in the patient reported by Matthews et al. (1993), ovulation was induced by administration of exogenous FSH and resulted in a successful pregnancy.</Attribute>
              <Citation>
                <ID Source="PubMed">8220432</ID>
              </Citation>
              <XRef DB="OMIM" ID="229070" Type="MIM" />
              <XRef DB="OMIM" ID="152780" Type="MIM" />
              <XRef DB="OMIM" ID="118850" Type="MIM" />
              <XRef DB="OMIM" ID="136435" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an Israeli woman with primary amenorrhea due to isolated deficiency of FSH, originally reported by Rabin et al. (1972), Matthews and Chatterjee (1997) identified the same 2-bp deletion found in the Italian patient by Matthews et al. (1993). The proband's 18-year-old daughter and her sister were both heterozygous for the 2-bp deletion; both had normal serum FSH levels and regular menstrual cycles, and the sister had 3 normal pregnancies, suggesting that reproductive function is not compromised in female heterozygotes.</Attribute>
              <Citation>
                <ID Source="PubMed">4344039</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9280841</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8220432</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 16-year-old girl with delayed puberty and hypogonadism due to FSH deficiency, Layman et al. (1997) identified compound heterozygosity for the FSHB 2-bp deletion and a c.151T-G transversion in exon 3 of the FSHB gene, resulting in a cys51-to-gly (C51G; 136530.0002) substitution. Her unaffected parents were each heterozygous for 1 of the mutations; a sister and a half sister who were heterozygous for the missense mutation had 2 and 3 children, respectively, and a half brother who carried C51G had normal puberty and normal semen analysis.</Attribute>
              <Citation>
                <ID Source="PubMed">9271483</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an 18-year-old man with hypogonadism due to isolated deficiency of FSH, Phillip et al. (1998) identified homozygosity for the 2-bp deletion in codon 61 of the FSHB gene. His unaffected parents and brother were heterozygous for the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">9624193</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Nagirnaja et al. (2010) referred to this mutation as 2631TGdel, Val61del2bp/87Ter.</Attribute>
              <Citation>
                <ID Source="PubMed">20488225</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FSHB" />
          </GeneList>
          <Name>FSHB, 2-BP DEL, 2631TG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 2631TG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="136530.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790596" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1365807" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915524" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9624193</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9280841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8220432</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9271483</ID>
          </Citation>
          <Comment>The FSHB c.236_237delTG (p.Val79GlufsTer27) variant is a frameshift variant predicted to result in premature truncation of the protein. The p.Val79GlufsTer27 variant is reported in four studies in which it is found in a total of four individuals affected with follicle-stimulating hormone (FSH) deficiency, including in three in a homozygous state (Matthews et al. 1993; Matthews et al. 1997; Phillip et al. 1998) and in one in a compound heterozygous state (Layman et al. 1997). The p.Val79GlufsTer27 variant is also reported to be present in six unaffected family members in a heterozygous state (Matthews et al. 1993; Layman et al. 1997; Phillip et al. 1998). The variant is absent from 34 controls (Layman et al. 1997) but is reported at a frequency of 0.00224 in the Ashkenazi Jewish population of the Genome Aggregation Database. Transfection of the p.Val79GlufsTer27 variant into CHO cells, showed no expression of FSH (Layman et al. 1997). The predicted truncation eliminates the last five cysteine residues of the protein, which are believed to be important for dimer stabilization. Based on collective evidence, the p.Val79GlufsTer27 variant is classified as pathogenic for isolated follicle-stimulating hormone deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FSHB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="A" referenceAllele="AGT" start="30255191" stop="30255193" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000510.2:c.236_237delTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="229070" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1204270" SubmissionDate="2021-09-30" DateLastUpdated="2023-03-04" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:180341" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617858" DateUpdated="2023-03-04" DateCreated="2017-12-19" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 51 amino acids are lost and replaced with 26 incorrect amino acids (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 9624193, 8220432, 20488225, 9271483)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FSHB" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:768372</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000510.2:c.236_237del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_57_20210930044205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1790596" TraitType="Disease" MappingType="XRef" MappingValue="229070" MappingRef="OMIM">
        <MedGen CUI="C5574957" Name="Hypogonadotropic hypogonadism 24 without anosmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1204270" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4048912" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37904" TraitType="Disease" MappingType="Name" MappingValue="HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA" MappingRef="Preferred">
        <MedGen CUI="C5574957" Name="Hypogonadotropic hypogonadism 24 without anosmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

